Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection.

Saved in:
Bibliographic Details
Title: Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection.
Authors: Parati MC; Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy., Pedersini R; Breast Unit-Medical Oncology, ASST Spedali Civili, Brescia, Italy., Perego G; Pharmacy Unit, IRCCS San Raffaele Hospital, Milan, Italy., Reduzzi R; Breast Unit, ASST Bergamo Ovest, Treviglio, BG, Italy., Savio T; Breast Unit, ASST Bergamo Ovest, Treviglio, BG, Italy., Cabiddu M; Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy., Borgonovo K; Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy., Ghilardi M; Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy., Luciani A; Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy., Petrelli F; Oncology Unit, Medical Science Department, ASST Bergamo Ovest, Treviglio, BG, Italy.
Source: Breast cancer (Dove Medical Press) [Breast Cancer (Dove Med Press)] 2022 Apr 12; Vol. 14, pp. 101-111. Date of Electronic Publication: 2022 Apr 12 (Print Publication: 2022).
Publication Type: Journal Article; Review
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101591856 Publication Model: eCollection Cited Medium: Print ISSN: 1179-1314 (Print) Linking ISSN: 11791314 NLM ISO Abbreviation: Breast Cancer (Dove Med Press) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-1314
DOI:10.2147/BCTT.S341857